Live·Open questions in longevity research
← Questions

Can aging human skin be shifted into a stable, youthful functional state, and what minimal set of changes in cells, the extracellular matrix, stem cell niches, the vasculature, and the nervous system is necessary and jointly sufficient to achieve and maintain this transition?

Does activating or blocking skin repair cells’ force-response protein stop contraction more safely after closure, depending on tension?

Fibroblasts can change the material surrounding them and generate contraction, so changing their activity could affect both wound tightening and later tissue movement. In the supplied laboratory evidence, reducing YAP together with a related protein reduces contraction, with one source reporting this effect specifically on abnormally stiff material [S1, S6].

The whole reason

However, reduced contraction alone does not establish recovered movement, spring-back, or freedom from harmful lasting cell states. Treating those outcomes as interchangeable could mistake an immediate reduction in pulling for durable recovery. Conversely, assuming that activation supports regeneration could overlook the reported benefits of YAP removal in injured heart tissue and the senescence-related findings in a separate heart-cell study [S7, S9].

The question in full

The question concerns whether skin repair cells should have a force-responsive protein switched on or suppressed once a wound has closed. These cells, called fibroblasts, help make and reshape the material around them; the protein is Yes-associated protein (YAP). The comparison is whether activating or inhibiting YAP better stops tissue contraction and restores movement and spring-back, without excessive scarring, senescence, or continuing or returning cell multiplication. It also asks whether tension in the surrounding material, the cells’ condition, and treatment timing change which approach works, and whether recovery lasts after treatment ends. The question assumes that YAP can support both contraction and regeneration, and that excessive inhibition may cause an inflammatory form of senescence; those assumptions require separate assessment.

Competing hypotheses

These hypotheses propose different mechanisms. Comparing their predictions helps identify observations that could distinguish them.

  1. 01Surviving skin fibroblasts must briefly dismantle their contractile machinery to stop pullingIn post-closure aged human skin equivalents, YAP (Yes-associated protein) permits protein cleavage that ends contraction without killing fibroblasts. Blocking cleavage should preserve force despite the usual gene response; permitting it should restore mobility in the same surviving cells.
  2. 02Regulatory partners determine whether a signal sustains or ends fibroblast contractionIn fibroblasts, regulatory partners determine whether Yes-associated protein (YAP) sustains or ends contraction. Changing those partners at fixed matrix tension and matched nuclear YAP must reverse force and mobility outcomes; regulatory scores must predict the reversal in held-out conditions.
  3. 03Different outcomes explain the apparent reversal of Yes-associated protein's effectsIn post-closure fibroblasts, the apparent reversal of Yes-associated protein (YAP) effects reflects mismatched outcomes. Matched measurements of force and lasting mobility would reject this explanation if activation restores function at one matrix tension and inhibition does so at another.
Each entry represents a published hypothesis. Where no hypotheses are published yet, the entries show possible answers to the scientific question.

What results would tell us about the hypotheses

Choose a possible result to see which hypothesis it would support, what the alternatives predict, and what would need to be tested next.

If we observe
In lineage-tracked, post-closure aged human skin equivalents, YAP activation produces a transient caspase-reporter pulse and cleavage of identified contractile-apparatus substrates before sustained loss of single-cell traction. The same fibroblasts survive, recover mobility, and remain nonproliferative after withdrawal. Genetic inhibition of the implicated executioner caspase, or cleavage-resistant replacement of a validated substrate, prevents force termination despite the normal YAP-associated transcriptional response. A calibrated caspase pulse with independently maintained survival bypasses the need for YAP activation. Absence of cleavage, preserved force termination after selective cleavage blockade, or an effect explained by cell death rejects this mechanism. Hypothetical result
Would support the hypothesis
Surviving skin fibroblasts must briefly dismantle their contractile machinery to stop pulling — In post-closure aged human skin equivalents, YAP (Yes-associated protein) permits protein cleavage that ends contraction without killing fibroblasts. Blocking cleavage should preserve force despite the usual gene response; permitting it should restore mobility in the same surviving cells.
Other hypotheses predict
  • Regulatory partners determine whether a signal sustains or ends fibroblast contraction — At fixed matrix tension and matched nuclear YAP abundance, selective recruitment or disruption of the competing transcription-factor partnerships reverses the sign of YAP's effect on traction, contraction persistence, and appendage-region mobility. In held-out conditions, measured relative regulatory scores predict the reversal boundary better than tension or total nuclear YAP alone. Selective executioner-caspase blockade does not prevent the successful transcriptionally driven exit. The hypothesis fails if partner manipulation changes reporter genes but cannot reverse functional outcomes, or if a continuous additive model predicts the data as well as the proposed selection rule.
  • Different outcomes explain the apparent reversal of Yes-associated protein's effects — A matched post-closure YAP-by-tension experiment reproduces opposite effects on molecular markers but finds no reversal in the direction of YAP's effect on independently measured active traction and durable tissue mobility. Apparent benefits of activation disappear when success requires force resolution, recoil, appendage displacement, absence of senescence, and absence of proliferative persistence in the same specimens after withdrawal. Replicated activation-dependent functional recovery in surviving, nonexpanding fibroblasts at one tension, together with inhibition-dependent recovery at another, rejects this explanation.
What to check next
After skin wound closure, does activating or inhibiting fibroblast YAP better stop contraction and restore movement without senescence or persistent cell multiplication?

These are hypothetical results. Selecting one shows what would follow from it; it does not confirm a hypothesis or change its assessment.

Comparing hypotheses

Compare the proposed mechanisms, the predictions that distinguish the hypotheses, and the observations that would count against each one.

01

Surviving skin fibroblasts must briefly dismantle their contractile machinery to stop pulling

Nonlethal proteolytic execution
Proposed mechanism

In post-closure aged human skin equivalents, YAP (Yes-associated protein) permits protein cleavage that ends contraction without killing fibroblasts.

Full text

Post-closure contractile termination requires a brief, nonlethal executioner-caspase pulse that dismantles the existing contractile apparatus in surviving fibroblasts. YAP activation permits this partial execution program by maintaining survival competence; it does not terminate contraction primarily by replacing the myofibroblast transcriptional program. Matrix tension determines whether dismantling remains survivable or progresses to apoptosis. The persistent substrate is uncleaved contractile machinery, rather than a self-sustaining transcriptional state. Appropriately timed YAP activation should therefore outperform inhibition only when it permits proteolytic disassembly without cell loss, senescence, or continued proliferation. This mechanism would stabilize SPV_3, with independent recovery of SPV_2 and surveillance of SPV_10 required.

What distinguishes its prediction

In lineage-tracked, post-closure aged human skin equivalents, YAP activation produces a transient caspase-reporter pulse and cleavage of identified contractile-apparatus substrates before sustained loss of single-cell traction.

Full text

The same fibroblasts survive, recover mobility, and remain nonproliferative after withdrawal. Genetic inhibition of the implicated executioner caspase, or cleavage-resistant replacement of a validated substrate, prevents force termination despite the normal YAP-associated transcriptional response. A calibrated caspase pulse with independently maintained survival bypasses the need for YAP activation. Absence of cleavage, preserved force termination after selective cleavage blockade, or an effect explained by cell death rejects this mechanism.

What would weaken the hypothesis

Regulatory partners determine whether a signal sustains or ends fibroblast contraction predicts instead: At fixed matrix tension and matched nuclear YAP abundance, selective recruitment or disruption of the competing transcription-factor partnerships reverses the sign of YAP's effect on traction, contraction persistence, and appendage-region mobility.

Full text

In held-out conditions, measured relative regulatory scores predict the reversal boundary better than tension or total nuclear YAP alone. Selective executioner-caspase blockade does not prevent the successful transcriptionally driven exit. The hypothesis fails if partner manipulation changes reporter genes but cannot reverse functional outcomes, or if a continuous additive model predicts the data as well as the proposed selection rule.

Different outcomes explain the apparent reversal of Yes-associated protein's effects predicts instead: A matched post-closure YAP-by-tension experiment reproduces opposite effects on molecular markers but finds no reversal in the direction of YAP's effect on independently measured active traction and durable tissue mobility. Apparent benefits of activation disappear when success requires force resolution, recoil, appendage displacement, absence of senescence, and absence of proliferative persistence in the same specimens after withdrawal. Replicated activation-dependent functional recovery in surviving, nonexpanding fibroblasts at one tension, together with inhibition-dependent recovery at another, rejects this explanation.

02

Regulatory partners determine whether a signal sustains or ends fibroblast contraction

Information and sensing
Proposed mechanism

In fibroblasts, regulatory partners determine whether Yes-associated protein (YAP) sustains or ends contraction.

Full text

YAP has no fixed post-closure sign because competing transcription-factor partnerships determine which regulatory program its activity executes. A TEAD-SMAD-dominated contractile program and an experimentally identifiable repair/disassembly program compete for regulatory selection. Tension changes the relative activation scores of those programs; YAP amplifies the selected program. Thus increasing YAP can either sustain contraction or promote its termination without requiring depletion of a cofactor, cell replacement, or a persistent bistable state. The causal substrate is current partner-specific enhancer occupancy. Restoring the appropriate regulatory selection should stabilize SPV_3 while preserving SPV_2 and avoiding SPV_10 deterioration.

What distinguishes its prediction

At fixed matrix tension and matched nuclear YAP abundance, selective recruitment or disruption of the competing transcription-factor partnerships reverses the sign of YAP's effect on traction, contraction persistence, and appendage-region mobility.

Full text

In held-out conditions, measured relative regulatory scores predict the reversal boundary better than tension or total nuclear YAP alone. Selective executioner-caspase blockade does not prevent the successful transcriptionally driven exit. The hypothesis fails if partner manipulation changes reporter genes but cannot reverse functional outcomes, or if a continuous additive model predicts the data as well as the proposed selection rule.

What would weaken the hypothesis

Surviving skin fibroblasts must briefly dismantle their contractile machinery to stop pulling predicts instead: In lineage-tracked, post-closure aged human skin equivalents, YAP activation produces a transient caspase-reporter pulse and cleavage of identified contractile-apparatus substrates before sustained loss of single-cell traction.

Full text

The same fibroblasts survive, recover mobility, and remain nonproliferative after withdrawal. Genetic inhibition of the implicated executioner caspase, or cleavage-resistant replacement of a validated substrate, prevents force termination despite the normal YAP-associated transcriptional response. A calibrated caspase pulse with independently maintained survival bypasses the need for YAP activation. Absence of cleavage, preserved force termination after selective cleavage blockade, or an effect explained by cell death rejects this mechanism.

Different outcomes explain the apparent reversal of Yes-associated protein's effects predicts instead: A matched post-closure YAP-by-tension experiment reproduces opposite effects on molecular markers but finds no reversal in the direction of YAP's effect on independently measured active traction and durable tissue mobility. Apparent benefits of activation disappear when success requires force resolution, recoil, appendage displacement, absence of senescence, and absence of proliferative persistence in the same specimens after withdrawal. Replicated activation-dependent functional recovery in surviving, nonexpanding fibroblasts at one tension, together with inhibition-dependent recovery at another, rejects this explanation.

03

Different outcomes explain the apparent reversal of Yes-associated protein's effects

Measurement and interpretation
Proposed mechanism

In post-closure fibroblasts, the apparent reversal of Yes-associated protein (YAP) effects reflects mismatched outcomes.

Full text

The apparent tension-dependent reversal of YAP's effect on safe contractile exit does not exist as a single phenomenon. The literature combines different outcomes: alpha-SMA disappearance, prevention of differentiation, established myofibroblast reversal, tissue contraction, regenerative growth, and avoidance of senescence. YAP activation can improve some of these while failing to restore post-closure mobility; inhibition can reduce force while independently increasing senescence. No direction therefore necessarily achieves the joint exit described in this L3. The proposed explanation is endpoint non-equivalence rather than a hidden mechanism that reverses YAP's functional sign. This hypothesis challenges whether either YAP direction stabilizes SPV_3 as claimed.

What distinguishes its prediction

A matched post-closure YAP-by-tension experiment reproduces opposite effects on molecular markers but finds no reversal in the direction of YAP's effect on independently measured active traction and durable tissue mobility.

Full text

Apparent benefits of activation disappear when success requires force resolution, recoil, appendage displacement, absence of senescence, and absence of proliferative persistence in the same specimens after withdrawal. Replicated activation-dependent functional recovery in surviving, nonexpanding fibroblasts at one tension, together with inhibition-dependent recovery at another, rejects this explanation.

What would weaken the hypothesis

Surviving skin fibroblasts must briefly dismantle their contractile machinery to stop pulling predicts instead: In lineage-tracked, post-closure aged human skin equivalents, YAP activation produces a transient caspase-reporter pulse and cleavage of identified contractile-apparatus substrates before sustained loss of single-cell traction.

Full text

The same fibroblasts survive, recover mobility, and remain nonproliferative after withdrawal. Genetic inhibition of the implicated executioner caspase, or cleavage-resistant replacement of a validated substrate, prevents force termination despite the normal YAP-associated transcriptional response. A calibrated caspase pulse with independently maintained survival bypasses the need for YAP activation. Absence of cleavage, preserved force termination after selective cleavage blockade, or an effect explained by cell death rejects this mechanism.

Regulatory partners determine whether a signal sustains or ends fibroblast contraction predicts instead: At fixed matrix tension and matched nuclear YAP abundance, selective recruitment or disruption of the competing transcription-factor partnerships reverses the sign of YAP's effect on traction, contraction persistence, and appendage-region mobility. In held-out conditions, measured relative regulatory scores predict the reversal boundary better than tension or total nuclear YAP alone. Selective executioner-caspase blockade does not prevent the successful transcriptionally driven exit. The hypothesis fails if partner manipulation changes reporter genes but cannot reverse functional outcomes, or if a continuous additive model predicts the data as well as the proposed selection rule.

No test is published for this question yet

The hypotheses above state the observations that could distinguish them. A proposed experiment for this question has not yet been published.

What to check next: After skin wound closure, does activating or inhibiting fibroblast YAP better stop contraction and restore movement without senescence or persistent cell multiplication?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Does activating or blocking skin repair cells’ force-response protein stop contraction more safely after closure, depending on tension?

What this question is asking

The question concerns whether skin repair cells should have a force-responsive protein switched on or suppressed once a wound has closed. These cells, called fibroblasts, help make and reshape the material around them; the protein is Yes-associated protein (YAP). The comparison is whether activating or inhibiting YAP better stops tissue contraction and restores movement and spring-back, without excessive scarring, senescence, or continuing or returning cell multiplication. It also asks whether tension in the surrounding material, the cells’ condition, and treatment timing change which approach works, and whether recovery lasts after treatment ends. The question assumes that YAP can support both contraction and regeneration, and that excessive inhibition may cause an inflammatory form of senescence; those assumptions require separate assessment.

What the terms mean
Fibroblast
A cell that produces and reshapes material around cells. Fibroblasts can occupy different functional states; the name does not identify one fixed level of contraction or cell multiplication.
Yes-associated protein (YAP)
A protein involved in regulating gene activity and cellular responses to mechanical surroundings. This question concerns whether increasing or decreasing its activity helps end contraction; its amount, location, and activity are related measurements but are not interchangeable.
Transcriptional coactivator with PDZ-binding motif (TAZ)
A gene-regulating protein studied alongside YAP. Several supplied experiments suppress both proteins, so their results do not isolate the effect of suppressing YAP alone; the full name includes a label for a protein-binding feature.
Post-closure
The period after a wound has closed. Closure does not, by itself, establish that tissue movement or internal repair has returned to normal; the supplied material gives no specific duration for this period.
Contraction, mobility, and recoil
Contraction is tissue tightening caused by cellular pulling; mobility is the ability of tissue to move; recoil is its ability to spring back after deformation. They are distinct outcomes, so less contraction does not by itself demonstrate restored mobility or recoil.
Extracellular matrix
The material surrounding cells, which cells can produce, pull against, and reshape. Its mechanical properties form part of the surroundings tested in the supplied studies.
Matrix tension, stretch, and stiffness
Tension is pulling force carried by the surrounding material, stretch describes its deformation, and stiffness describes resistance to deformation. These are different properties, so evidence about stiffness does not automatically establish the effect of tension.
Fibrosis
Excessive accumulation of scar-like supporting material in tissue. Reducing fibrosis is one relevant outcome, but it does not alone establish recovered movement or lasting safety.
Senescence
A lasting cell state involving withdrawal from ordinary cell multiplication and changes in cell behavior. Senescence-associated measurements indicate features of that state; they do not by themselves establish all its consequences for tissue recovery.
Senescence-associated secretory phenotype (SASP)
A pattern of substances released by senescent cells that can include inflammatory signals. A reported SASP signature is a pattern of measurements associated with that behavior, rather than direct proof of later tissue recurrence.
Proliferation and proliferative persistence
Proliferation means cell multiplication. Persistence means that multiplication continues or returns when the desired repair response should have subsided.
Knockdown, inhibition, activation, and genetic removal
Knockdown reduces production of a target protein, inhibition reduces its function, and activation increases its activity. Genetic removal disables the gene supplying it; these interventions differ and cannot automatically be treated as equivalent.
Fibronectin and collagen
Proteins that form parts of the extracellular matrix. Fibronectin is the matrix component described as less stretched in S2, while collagen forms the experimental supports described for S4.
Alpha-smooth muscle actin
A protein associated with the cell’s contractile machinery. Its level serves as a marker of contractile cell state in S2, rather than a direct measurement of recovered tissue movement.
Nucleus and YAP location
The nucleus is the cell compartment containing its genetic material. The supplied studies distinguish YAP inside this compartment from YAP in the surrounding cell interior; location is not itself a measurement of contraction or safety.
Focal adhesion kinase (FAK)
A signaling protein involved in how cells respond through their attachments to surrounding material. S4 inhibits this protein and observes reduced remodeling alongside reduced YAP expression.
Hippo pathway
A system of signals involved in regulating YAP-related cell behavior. S9 concerns mouse heart fibroblasts with disrupted regulation in this system, which is a different manipulation from directly inhibiting YAP.
Engrailed-1 (En-1)
A gene-regulating factor whose activation is reported as prevented in S10. It is part of that source’s account of scarless repair, not a demonstrated explanation of recovery after closure.
Regeneration
Rebuilding damaged tissue. The question requires functional recovery as well as reduced scarring, so a report of regeneration does not automatically establish every outcome it asks about.
Engineered tissue-growth model
An experimentally constructed setting in which cells grow and organize tissue. S2 uses such a model, rather than examining an already-closed skin wound.
What the question takes for granted
Premise only partly supported
YAP has both contraction-promoting and regeneration-supporting activity; excessive inhibition may induce inflammatory senescence, and cell state, matrix tension, and timing can reverse which intervention direction supports persistent recovery.

YAP is a protein involved in how fibroblasts respond to their surroundings, and the matrix is the material those cells build and pull against. The assumption is that the same protein can sustain tightening or help rebuild tissue, while suppressing it too strongly can leave cells in a lasting, inflammation-associated state. If established, this would make the choice between activation and inhibition depend on the surrounding forces and the stage of repair.

Reduced contraction after combined YAP and related-protein suppression supports a contraction-promoting role [S1, S6]. Findings involving matrix stretch, stiffness, and YAP location support sensitivity to the mechanical surroundings, but do not establish a reversal in the preferred treatment direction [S2, S3, S6]. The supplied sources do not establish that excessive YAP inhibition causes inflammatory senescence or that YAP activation supports regeneration after closure. Instead, S10 reports regeneration associated with YAP inhibition, S7 reports benefits from fibroblast YAP removal in heart injury, and S9 reports senescence-associated changes in heart fibroblasts lacking a regulatory pathway. These findings challenge a general activation-benefit or inhibition-harm assumption without settling the specific skin question.S1S2S3S6S7S9S10

The same question asked without the part nothing read establishes:

  • After skin wound closure, does activating or inhibiting fibroblast YAP better stop contraction and restore movement without senescence or persistent cell multiplication?
  • Does tension in the material surrounding fibroblasts change the effects of YAP activation or inhibition on contraction and lasting recovery after skin wound closure?
What turns on the answer
  • Activation produces safer, lasting recovery If activation stops contraction while preserving movement and avoiding the specified harmful cell states, YAP activity would support recovery in that post-closure setting. Suppression could then interfere with that recovery, even though suppression reduces contraction in other supplied laboratory settings.
  • Inhibition produces safer, lasting recovery If inhibition reduces cell-generated pulling and movement recovers without senescence or returning cell multiplication, continued YAP activity would be sustaining the unwanted state in that setting. Activation could then prolong tightening instead of ending it.
  • The safer direction depends on surrounding tension If different tension conditions favor opposite interventions, the surroundings would determine whether activation or inhibition ends contraction with lasting functional recovery. Applying one direction across those conditions could improve one tissue state while sustaining contraction or harmful cell behavior in another.
  • Neither direction produces the required recovery An intervention could reduce contraction while leaving movement impaired or allowing harmful cell states to persist. In that case, changing YAP alone would not meet the question’s combined requirement for function, safety, and persistence after withdrawal.
Why it matters

Fibroblasts can change the material surrounding them and generate contraction, so changing their activity could affect both wound tightening and later tissue movement. In the supplied laboratory evidence, reducing YAP together with a related protein reduces contraction, with one source reporting this effect specifically on abnormally stiff material [S1, S6]. However, reduced contraction alone does not establish recovered movement, spring-back, or freedom from harmful lasting cell states. Treating those outcomes as interchangeable could mistake an immediate reduction in pulling for durable recovery. Conversely, assuming that activation supports regeneration could overlook the reported benefits of YAP removal in injured heart tissue and the senescence-related findings in a separate heart-cell study [S7, S9].

Partly answered already

S1 and S6 establish that combined YAP and TAZ suppression can reduce contraction in laboratory settings, and S6 identifies dependence on abnormal matrix stiffness. S2 and S3 report relationships between mechanical surroundings and YAP location. The inference from these findings is that mechanical context matters, not that it reverses which treatment is safer. S7, S9, and S10 also challenge parts of the proposed activation-benefit and inhibition-harm framing. None of the supplied sources settles the post-closure comparison, restoration of movement, or durable recovery without the specified harmful cell states.S1S6S2S3S7S9S10

What the literature establishes
  • In laboratory-grown cells, combined knockdown of YAP and transcriptional coactivator with PDZ-binding motif (TAZ) reduced contractile function more effectively than targeting individual genes for the cell’s internal supporting framework.S1
  • In an engineered tissue-growth model, cells in regions with less-stretched fibronectin matrix were quieter and multiplied less. They also had less alpha-smooth muscle actin, a marker associated with contractile cells, and YAP was located outside the nucleus.S2
  • In skin fibroblasts grown on supporting materials of different stiffness, almost all cells retained YAP outside the nucleus on the softer material, while most showed YAP both inside and outside the nucleus on the stiffer material. This reports protein location, not recovery after wound closure.S3
  • In adult human skin fibroblasts in stretched, three-dimensional collagen supports, inhibition of focal adhesion kinase (FAK) reduced remodeling of the surrounding extracellular matrix. Reduced remodeling was correlated with lower YAP expression; this was not a direct comparison of YAP activation and inhibition.S4
  • Combined YAP and TAZ knockdown reduced matrix production, contraction, and cell multiplication in laboratory-grown cells, with the reported effects occurring exclusively on abnormally stiff matrices.S6
  • Genetic removal of YAP specifically from fibroblasts reduced heart scarring and impaired heart function following a heart attack or prolonged nerve-and-hormone stimulation.S7
  • Mouse heart fibroblasts lacking normal Hippo pathway regulation showed increased senescence-associated and senescence-associated secretory phenotype (SASP) signatures. The supplied finding does not test YAP inhibition or establish comparative treatment safety.S9
  • A water-rich material used in wound repair was reported to inhibit YAP without light activation, prevent activation of Engrailed-1 (En-1), and promote scarless regeneration. The supplied evidence does not isolate treatment after closure.S10
What it does not settle
  • No supplied source directly compares fibroblast YAP activation with inhibition after skin wound closure for safely terminating contraction.S1S2S3S4S5S6S7S8S9S10
  • The sources do not establish whether matrix tension reverses the preferred intervention direction. Associations with stretch, differences in stiffness, and changes in YAP location do not establish that reversal.S2S3S6
  • Restored tissue movement and spring-back, absence of senescence-associated recurrence, and freedom from persistent or returning cell multiplication are not demonstrated together in the relevant post-closure setting.
  • The supplied evidence does not establish a post-closure treatment window, the relevant cell conditions, the magnitude of functional benefit, or how long recovery persists after treatment ends.
  • It remains unsettled whether excessive YAP inhibition causes inflammatory senescence in this setting. The supplied senescence finding concerns a different manipulation in mouse heart fibroblasts.S9
  • The supplied material does not establish that any of these findings produce a stable, youthful functional state in aging human skin.
Where the sources disagree
  • S7 challenges a general expectation that fibroblast YAP activation is preferable to inhibition: removing YAP reduced heart scarring and dysfunction. This conflicts with a broad activation-benefit premise, but does not resolve the comparison after skin wound closure.S7
  • S9 complicates the premise that senescence is principally a danger of excessive inhibition: it reports increased senescence and inflammatory-secretory signatures in mouse heart fibroblasts lacking Hippo regulation. This is not a direct activation-versus-inhibition comparison and does not establish either direction’s safety after closure.S9
  • S10 reports scarless regeneration alongside YAP inhibition, challenging any general framing in which regeneration requires YAP activation. It does not establish whether the same relationship holds specifically after closure.S10
Sources read · 10

4 literature searches, 10 full texts; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

Combined control of the fibroblast contractile program by YAP and TAZ. · American journal of physiology. Lung cellular and molecular physiology · 2022

“Combined knockdown targeting YAP/TAZ was more effective than targeting any of the individual cytoskeletal genes in reducing contractile function.”

Does not settle: This in vitro study does not examine post-closure wounds, YAP activation versus inhibition as a safety comparison, matrix tension-dependent direction of intervention, restored mobility, senescence, or renewed proliferative persistence.

S2Partly answers it

Tensile forces drive a reversible fibroblast-to-myofibroblast transition during tissue growth in engineered clefts. · Science advances · 2018

“The FN matrix deposited and remodeled by these cells in the tissue interior was less stretched, and cells adopted a quiescent, less proliferative phenotype with low α-SMA expression and cytosolic localization of YAP.”

Does not settle: This engineered-cleft tissue-growth study links matrix tension and YAP localization with fibroblast/myofibroblast phenotypes, but does not compare post-closure YAP activation versus inhibition, establish safety, assess senescence, or determine an intervention that restores mobility without renewed proliferative persistence.

S3Partly answers it

αII-spectrin and βII-spectrin do not affect TGFβ1-induced myofibroblast differentiation. · Cell and tissue research · 2018

“on 2 kPa, almost all cells displayed cytoplasmic retention of YAP (Fig. a–c), while on 50 kPa, the majority of cells showed both nuclear and cytoplasmic localization of YAP (Fig. d–f).”

Does not settle: This source does not compare YAP activation with inhibition after wound closure, measure contraction termination, mobility restoration, senescence, or persistent proliferation. It reports YAP localization in dermal fibroblasts on 2 versus 50 kPa substrates, not post-closure outcomes.

S4Partly answers it

Disrupting biological sensors of force promotes tissue regeneration in large organisms. · Nature communications · 2021

“Using a contraction assay, we observed that fibroblasts lost their ability to remodel the surrounding ECM environment upon FAKI treatment (Fig. ) . This attenuation of remodeling was also correlated with a decrease in YAP expression, a downstream transcription factor of the FAK pathway (Fig. ) , .”

Does not settle: This does not test post-closure treatment, direct YAP activation versus inhibition, safety, restoration of mobility, senescence, or renewed proliferative persistence. It examines adult human dermal fibroblasts in strained 3D collagen scaffolds with FAK inhibition, not a post-closure wound setting.

S5Background

YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. · The European respiratory journal · 2025

“These findings suggest that YAP in macrophages may promote fibroblast transition during lung injury.”

Does not settle: It does not test fibroblast YAP activation versus inhibition after closure, contraction termination, matrix tension, restored mobility, senescence, or proliferative persistence.

S6Partly answers it

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. · American journal of physiology. Lung cellular and molecular physiology · 2015

“Knockdown of YAP and TAZ together in vitro attenuates key fibroblast functions, including matrix synthesis, contraction, and proliferation, and does so exclusively on pathologically stiff matrices.”

Does not settle: This source does not study post-closure wound healing, compare safety of YAP activation versus inhibition, or report restoration of mobility, senescence, or renewed proliferative persistence. Its in vitro result concerns combined YAP/TAZ knockdown on pathologically stiff matrices; it does not establish that matrix tension determines the direction that restores mobility.

S7Contradicts it

Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition. · JACC. Basic to translational science · 2020

“Using fibroblast-restricted genetic inactivation of endogenous YAP, we show that YAP deletion attenuates myocardial fibrosis and cardiac dysfunction in response to MI or chronic neuroendocrine stimulation.”

Does not settle: This source does not establish effects specifically after wound closure, compare safety of YAP activation versus inhibition for terminating contraction, test matrix tension as the determinant of direction, or assess restored mobility, senescence, or renewed proliferative persistence.

S8Partly answers it

SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation. · Experimental cell research · 2023

“Knockdown of YAP1 decreased the fibrosis-related markers, such as α-SMA, collagen I and Fibronectin, in SPARC-treated HTFs.”

Does not settle: This HTF study does not test post-closure contraction termination, YAP activation versus inhibition safety, matrix tension, restoration of mobility, senescence, or renewed proliferative persistence.

S9Contradicts it

YAP-Induced Glycolysis Drives Fibroinflammation and Disrupts Fibroblast Fidelity. · Circulation research · 2025

“Both senescence and SASP signature are increased in Lats1/ 2 ΔCF RA and in Hippo-deficient CFs (CF4) ( ).”

Does not settle: This source does not assess post-closure contraction, YAP inhibition, matrix tension, restoration of mobility, or comparative safety. It reports senescence/SASP signatures in Hippo-deficient cardiac fibroblasts in mice.

S10Partly answers it

Mechanoregulative hydrogel facilitates rapid scarless healing by self-adaptive control of wound niche at different stages. · Science advances · 2025

“In addition, it can inhibit YAP without light activation ( ), thereby preventing En-1 activation and promoting scarless wound regeneration ( ).”

Does not settle: It does not establish post-closure YAP activation versus inhibition for terminating contraction, whether matrix tension determines the preferred direction, or effects on mobility, senescence, or renewed proliferative persistence.

← Every open question